High expression of these genes in tumor tissue, were related to a low risk of recurrence and better survival rate in all subtypes of BC patients, ER positive patients, luminal-A patients, luminal-B patients and clinical stage III patients (Additional File 7). This evidence concerns the gene ESR1 and neoplasm.